BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Carson M, Kerrigan S. Quantification of suvorexant in urine using gas chromatography/mass spectrometry. Journal of Chromatography B 2017;1040:289-94. [DOI: 10.1016/j.jchromb.2016.10.042] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Skillman B, Kerrigan S. Quantification of suvorexant in blood using liquid chromatography-quadrupole/time of flight (LC-Q/TOF) mass spectrometry. Journal of Chromatography B 2018;1091:87-95. [DOI: 10.1016/j.jchromb.2018.05.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Iqbal M, Ezzeldin E, Khalil NY, Alam P, Al-rashood KA. UPLC-MS/MS determination of suvorexant in urine by a simplified dispersive liquid-liquid micro-extraction followed by ultrasound assisted back extraction from solidified floating organic droplets. Journal of Pharmaceutical and Biomedical Analysis 2019;164:1-8. [DOI: 10.1016/j.jpba.2018.10.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
3 Skillman B, Kerrigan S. CYP450-Mediated metabolism of suvorexant and investigation of metabolites in forensic case specimens. Forensic Sci Int 2020;312:110307. [PMID: 32473525 DOI: 10.1016/j.forsciint.2020.110307] [Reference Citation Analysis]
4 Rajana N, Devi DR, Kumar Reddy DN, Babu JM, Basavaiah K, Balakumaran K. Characterization of Five Oxidative Degradation Impurities and One Process Impurity of Suvorexant Drug Substance by LC-MS/MS, HR-MS and 1D, 2D NMR: Validation of Suvorexant Drug Substance and Process Impurities by HPLC and UPLC. J Chromatogr Sci 2020;58:433-44. [PMID: 32134104 DOI: 10.1093/chromsci/bmaa003] [Reference Citation Analysis]
5 Waters B, Hara K, Ikematsu N, Takayama M, Matsusue A, Kashiwagi M, Kubo S. Tissue Distribution of Suvorexant in Three Forensic Autopsy Cases. Journal of Analytical Toxicology 2018;42:276-83. [DOI: 10.1093/jat/bkx110] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
6 Sullinger S, Bryand K, Kerrigan S. Identification of Suvorexant in Urine Using Liquid Chromatography-Quadrupole/Time-of-Flight Mass Spectrometry (LC-Q/TOF-MS). J Anal Toxicol 2017;41:224-9. [PMID: 28035034 DOI: 10.1093/jat/bkw132] [Reference Citation Analysis]
7 Iqbal M, Khalil NY, Ezzeldin E, Al-Rashood KA. Simultaneous Detection and Quantification of Three Novel Prescription Drugs of Abuse (Suvorexant, Lorcaserin and Brivaracetam) in Human Plasma by UPLC-MS-MS. J Anal Toxicol 2019;43:203-11. [PMID: 30295849 DOI: 10.1093/jat/bky078] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
8 Mogollón NGS, Quiroz-Moreno CD, Prata PS, de Almeida JR, Cevallos AS, Torres-Guiérrez R, Augusto F. New Advances in Toxicological Forensic Analysis Using Mass Spectrometry Techniques. J Anal Methods Chem 2018;2018:4142527. [PMID: 30228926 DOI: 10.1155/2018/4142527] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
9 Chen Z, Gao Y, Zhong D. Technologies to improve the sensitivity of existing chromatographic methods used for bioanalytical studies. Biomed Chromatogr 2020;34:e4798. [PMID: 31994210 DOI: 10.1002/bmc.4798] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
10 Skillman B, Kerrigan S. Identification of Suvorexant in Blood Using LC–MS-MS: Important Considerations for Matrix Effects and Quantitative Interferences in Targeted Assays. Journal of Analytical Toxicology 2020;44:245-55. [DOI: 10.1093/jat/bkz083] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]